SBI International Access vs Edelweiss US Value Equity Offshore Fund compare
SBI US Specific Equity Active FoF - Regular Plan - Growth
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Average | Very High |
| Asset Size (Cr) | ₹1061 Cr | ₹182 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 22 Mar 2021 | 07 Aug 2013 |
| Category | Gold | Gold |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE 500 | BSE India Bond Index |
| Turn Over | 37% | 18% |
| Expense Ratio | 1.6 | 2.33 |
| Manager | Pradeep Kesavan | Bhavesh Jain |
| ISIN Code | INF200KA1T96 | INF843K01ED9 |
| Exits Load | SBI International Access - US Equity FOF - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 90 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 1.21% | -0.39% |
| 6 Month | 30.82% | 14.17% |
| 1 Year | 18.03% | 5.71% |
| 3 Year | 24.95% | 11.93% |
| 5 Year | - | 14.48% |
SIP Return Analysis
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | 8.29% | 4.8% |
| 1 Year | 38.92% | 15.03% |
| 3 Year | 26.07% | 13.42% |
| 5 Year | - | 11.91% |
Rolling Lumpsum Returns
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 14.25% | 9.08% |
| 3 Year | 12.97% | 9.77% |
| 5 Year | - | 11.4% |
Risk Management
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.75% | 12.43% |
| Sharp | 1.17% | 0.44% |
| Beta | 1.09% | 0.77% |
| Alpha | -1.52% | -7.59% |
Fund Managers
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Pradeep Kesavan | Bhavesh Jain |
| Total AUM | ₹434274 Cr | ₹0 Cr |
| Funds Managed | 43 | 22 |
| SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
SBI US Specific Equity Active FoF - Regular Plan - Growth |
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 100 | 100 |
Sector Allocation
| Scheme Name |
SBI US Specific Equity Active FoF - Regular Plan - Growth |
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 100 | 100 |
Top Comparisons
Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth
3Y Returns12.11%
INVESCO INDIA AGGRESSIVE HYBRID FUND - Regular Plan - Growth
3Y Returns15.41%
Kotak US Specific Equity Passive FOF - Regular Plan - Growth
3Y Returns34.55%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns11.93%
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
3Y Returns20.44%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
3Y Returns21.45%
Franklin U.S. Opportunities Equity Active FOF - Regular - Growth
3Y Returns25.3%
Sundaram Global Brand Theme - Equity Active FOF Regular Growth
3Y Returns22.27%